The association between the dietary index for gut microbiota and metabolic dysfunction-associated fatty liver disease: a cross-sectional study
Authors:
Top Cited Papers
Open Access
- 17 January 2025
- journal article
- research article
- Published by Springer Nature in Diabetology & Metabolic Syndrome
- Vol. 17 (1) , 1-11
Abstract
The relationship between the gut microbiome and metabolic dysfunction-associated fatty liver disease (MAFLD) has garnered increasing attention. However, the association between the dietary index for gut microbiota (DI-GM), a measure of microbiome diversity, and MAFLD has yet to be fully explored. Data from the 2017–2020 National Health and Nutrition Examination Survey (NHANES) were analyzed, including 7243 participants. The association between DI-GM and MAFLD was investigated using weighted logistic regression, restricted cubic spline (RCS), and subgroup analyses. A notable inverse association was identified between DI-GM and the prevalence of MAFLD, with each 1-point increase in DI-GM corresponding to a 6.1% reduction in MAFLD prevalence (OR = 0.939, 95% CI: 0.901–0.980). Individuals with a DI-GM score of 6 or higher had an adjusted OR of 0.794 (95% CI: 0.665–0.947) compared to those with a DI-GM score of 0–3. RCS analysis further revealed a linear relationship between DI-GM and MAFLD risk. Additionally, subgroup analyses suggested that race may modify the association between DI-GM and MAFLD (P for interaction < 0.05). DI-GM is inversely associated with MAFLD prevalence, and race appears to be a significant modifier of this relationship.Keywords
Funding Information
- National High Level Hospital Clinical Research Funding (BJ-2023-083, BJ-2023-083, BJ-2023-083, BJ-2023-083)
This publication has 64 references indexed in Scilit:
- Gut symbionts alleviate MASH through a secondary bile acid biosynthetic pathwayCell, 2024
- Association Between the Sulfur Microbial Diet and Risk of Colorectal CancerJAMA Network Open, 2021
- The use of an in-vitro batch fermentation (human colon) model for investigating mechanisms of TMA production from choline, l-carnitine and related precursors by the human gut microbiotaEuropean Journal of Nutrition, 2021
- Mechanisms and disease consequences of nonalcoholic fatty liver diseaseCell, 2021
- Fecal Microbiome Distinguishes Alcohol Consumption From Alcoholic Hepatitis But Does Not Discriminate Disease SeverityHepatology, 2020
- Fatty Liver Disease Caused by High-Alcohol-Producing Klebsiella pneumoniaeCell Metabolism, 2019
- Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic SteatohepatitisHepatology, 2019
- Vibration-Controlled Transient Elastography to Assess Fibrosis and Steatosis in Patients With Nonalcoholic Fatty Liver DiseaseClinical Gastroenterology and Hepatology, 2019
- Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysisJournal of Hepatology, 2016
- Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009Hepatology, 2015